Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03925623 · ClinicalTrials.gov registry record
Design Factors for Evaluating Child Resistant Packaging
A clinical trial, sponsored by Michigan State University.
- Completed
- Registry status
- 27
- Enrollment target
NCT03925623: Completed study, sponsored by Michigan State University.
NCT03925623 is a clinical trial that has completed, run by Michigan State University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03925623 has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Each year over 59,000 children under the age of 5 are taken to emergency rooms (equivalent to 4 busloads of children arriving every day to the ER) because they were able to get into medication containers unsupervised. 95 percent of these ER visits occurred due to the child getting into medicine when an adult was not looking. Child resistant containers (CRC) are intended to restrict entry by imposing a cognitive barrier (the child must understand how to operate the CRC mechanism in order to open it) and a physical barrier (the child must posses the motor skills necessary to operate the CRC). Investigators are testing a design which changes the physical area available for grip utilizing anthropometric data that, in theory, would exclude children and enable adults. Investigators will evaluate the proposed design's effectiveness in two ways (1: cognitive barrier) will the child understand where they need to specifically grip the cap with their fingers and (2: physical barrier) will the child be able to use an appropriate gripping strategy to apply enough torque to rotate the cap and open it.
Primary Outcome
Openings are recorded in binary fashion (child was successful yes/no)
Interventions
- OTHER Novel approaches for the design of child resistant closures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2018-09-28 |
What the finished NCT03925623 record still lists
NCT03925623 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Novel approaches for the design of child resistant closures is the first listed.
NCT03925623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03925623 about?
NCT03925623 is a clinical study titled "Design Factors for Evaluating Child Resistant Packaging". Each year over 59,000 children under the age of 5 are taken to emergency rooms (equivalent to 4 busloads of children arriving every day to the ER) because they were able to get into medication containers unsupervised. 95 percent of these ER visits occurred due to the child getting into medicine when...
What is the current status of trial NCT03925623?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2017-12-14. Estimated completion is 2018-09-28.
What interventions are being tested in trial NCT03925623?
The interventions under investigation include: Novel approaches for the design of child resistant closures (OTHER).
Who is sponsoring clinical trial NCT03925623?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI